Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9A347

Entry ID Method Resolution Chain Position Source
AF-Q9A347-F1 Predicted AlphaFoldDB

No variants for Q9A347

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q9A347

No associated diseases with Q9A347

3 regional properties for Q9A347

Type Name Position InterPro Accession
domain DALR anticodon binding 517 - 630 IPR008909
domain Arginyl-tRNA synthetase, catalytic core domain 114 - 177 IPR035684-1
domain Arginyl-tRNA synthetase, catalytic core domain 210 - 503 IPR035684-2

Functions

Description
EC Number 6.1.1.19 Ligases forming aminoacyl-tRNA and related compounds
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
arginine-tRNA ligase activity Catalysis of the reaction: ATP + L-arginine + tRNA(Arg) = AMP + diphosphate + L-arginyl-tRNA(Arg).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

1 GO annotations of biological process

Name Definition
arginyl-tRNA aminoacylation The process of coupling arginine to arginyl-tRNA, catalyzed by arginyl-tRNA synthetase. The arginyl-tRNA synthetase is a class-I synthetase. The activated amino acid is transferred to the 2'-OH group of an alanine accetping tRNA. The 2'-O-aminoacyl-tRNA will ultimately migrate to the 3' position via transesterification.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNDLKRSLSE AAAAAFQAAG LPPEFGRVTA SDRPDLADFQ CNGALAAAKS AKRNPREIAV
70 80 90 100 110 120
QVVDILKGDP RLASVEIAGV GFINMRVSDE ALSARAREIA SDDRTGAQLL ETPRRVLIDY
130 140 150 160 170 180
AGPNVAKPMH VGHLRASIIG ESVKRLYRFR GDDVVGDAHF GDWGFQMGLL ISAIMDEDPF
190 200 210 220 230 240
INALMEKLPE APRGFSSADE AKVMAEFEKR ITLADLDRIY PAASVRQKED PAFKERARKA
250 260 270 280 290 300
TAELQNGRFG YRLLWRHFVN VSRVALEREF HALGVDFDLW KGESDVNDLI EPMVLQLEAK
310 320 330 340 350 360
GLLVQDQGAR IVRVAREGDK RDVPPLLVVS SEGSAMYGTT DLATILDRRK SFDPHLILYC
370 380 390 400 410 420
VDQRQADHFE TVFRAAYLAG YAEEGALEHI GFGTMNGADG KPFKTRAGGV LKLHDLIEMA
430 440 450 460 470 480
REKARERLRE AGLGAELSEE QFEDTAHKVG VAALKFADLQ NFRGTSYVFD LDRFTSFEGK
490 500 510 520 530 540
TGPYLLYQSV RIKSVLRRAA ESGAVAGRVE IHEPAERDLA MLLDAFEGAL QEAYDKKAPN
550 560 570 580 590
FVAEHAYKLA QSFSKFYAAC PIMSADTETL RASRLTLAET TLRQLELALD LLGIEAPERM